RxDoctor Payments Data

Carl Garabedian, MD

Pediatric Cardiology · Spokane, WANPI 1083666127

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Edwards Lifesciences at 30.2% of the total. Reporting peaked in 2022 at $3,608 and has fallen 92.0% since, to $288 in 2025.

$10,039in general payments, 2019–2025

Across 52 payments — averaging $193.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$3K
  • Medtronic$2K
  • Abbott$2K
  • Bayer$2K
  • Merck$62
  • Renata Medical, Inc.$24
  • plus $21 from 1 others
$11,539in research payments, 2019–2025

Across 13 payments — averaging $887.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$12K

What the payments were for

  • Consulting fees$4,10041%
  • Travel & lodging$3,62536%
  • Food & beverage$2,31423%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences2$3,030
Medtronic(2 entities)26$2,444
Abbott19$2,359
Bayer1$2,100
Merck2$62
Renata Medical, Inc.1$24
Actelion Pharmaceuticals US, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,039 in reported general payments places this provider in the 85th percentile of 49 pediatric cardiology providers in Washington.

See all pediatric cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$7,284
Medicare patients
23
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tadalafil12$20,875
LanoxinDigoxin12$10,804
Metoprolol Succinate15$197
JantovenWarfarin Sodium11$82

Paid to pharmacies, not to this prescriber.

Other pediatric cardiology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →